000180390 001__ 180390
000180390 005__ 20240229145617.0
000180390 0247_ $$2doi$$a10.1007/s00066-022-01970-x
000180390 0247_ $$2pmid$$apmid:35723708
000180390 0247_ $$2ISSN$$a0179-7158
000180390 0247_ $$2ISSN$$a1439-099X
000180390 037__ $$aDKFZ-2022-01304
000180390 041__ $$aGerman
000180390 082__ $$a610
000180390 1001_ $$0P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aRühle, Alexander$$b0$$eFirst author
000180390 245__ $$aWeekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial. [Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie].
000180390 260__ $$aHeidelberg$$bSpringer Medizin$$c2022
000180390 3367_ $$2DRIVER$$aarticle
000180390 3367_ $$2DataCite$$aOutput Types/Journal article
000180390 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1674633344_13517$$xEditorial
000180390 3367_ $$2BibTeX$$aARTICLE
000180390 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000180390 3367_ $$00$$2EndNote$$aJournal Article
000180390 500__ $$aLiteratur kommentiert /Editorial Material  lt. WOS /  2022 Oct;198(10):966-969 / #EA:E055#LA:E055#
000180390 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000180390 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000180390 7001_ $$0P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aNicolay, Nils$$b1$$eLast author
000180390 773__ $$0PERI:(DE-600)2003907-4$$a10.1007/s00066-022-01970-x$$gp. s00066-022-01970-x$$n10$$p966-969$$tStrahlentherapie und Onkologie$$v198$$x0179-7158$$y2022
000180390 909CO $$ooai:inrepo02.dkfz.de:180390$$pVDB
000180390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000180390 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000180390 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000180390 9141_ $$y2022
000180390 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-26$$wger
000180390 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-26
000180390 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-26
000180390 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-26
000180390 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSTRAHLENTHER ONKOL : 2021$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-11
000180390 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-11
000180390 9202_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x0
000180390 9201_ $$0I:(DE-He78)FR01-20160331$$kFR01$$lDKTK FR zentral$$x0
000180390 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x1
000180390 9200_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x0
000180390 980__ $$ajournal
000180390 980__ $$aVDB
000180390 980__ $$aI:(DE-He78)FR01-20160331
000180390 980__ $$aI:(DE-He78)E055-20160331
000180390 980__ $$aUNRESTRICTED